Harpoon Therapeutics Inc (HARP) has issued an update.
Harpoon has officially concluded a merger, terminating its previous “at-the-market” equity offering and effectively delisting its common stock from Nasdaq. Shareholders of Harpoon are now entitled to a merger consideration for their shares, except for certain excluded shares. Additionally, unvested stock options have become fully vested and exercisable, while other financial instruments like warrants have been adjusted to align with the merger’s terms. As part of the merger’s completion, changes in Harpoon’s board of directors occurred, with the previous board members resigning and being replaced by the directors and officers of the merger subsidiary.
See more data about HARP stock on TipRanks’ Stock Analysis page.
